Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04106336
Other study ID # rTMS in cannabis use disorder
Secondary ID
Status Not yet recruiting
Phase Early Phase 1
First received
Last updated
Start date October 1, 2019
Est. completion date December 30, 2020

Study information

Verified date September 2019
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 30, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- 18to 50 years of age

- cannabis use disorder according to DSM 5 definition

- clear consent to participate in study

Exclusion Criteria:

- cardiac peacemaker

- metal implant in the head as participate will be applied to magnetic field of TMS

- current intake of any medication affect cognition (as anti psychotic and anti epileptic)

- current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .

- age younger than 18 and older than 50 years

Study Design


Related Conditions & MeSH terms


Intervention

Device:
rTMS
Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Determination of role of rTMS for reducing cannabis craving Incidenc of cannabis craving after rTMS 1 year
Secondary Estimation of cortical excitability in cannabis addict Incidence of cannabis craving after cortical excitability 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04964739 - Gender/Sex & CUD Remission N/A
Not yet recruiting NCT06225232 - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study Phase 2
Completed NCT04923230 - Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse N/A
Completed NCT04902092 - Brain Exercise and Addiction Trial N/A
Recruiting NCT05064319 - Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders Phase 2
Active, not recruiting NCT04567394 - Cannabis Use Disorder Treatment Study N/A